Abstract
Background: Quality of life is a multidimensional concept that includes physical, emotional and social components associated with the disease. The use of tools to assess the Quality of Life Health Related (HRQOL) has increased in recent decades. Common variable immunode ciency (CVID) is the most commonly diagnosed primary immunode ciency.
Objective: To evaluate the quality of life in patients with CVID using the questionnaire SF -36.
Patients and method: A descriptive cross-sectional survey included 23 patients diagnosed with CVID, belonging to the Immunode ciency Clinic Service of Allergology and Clinical Immunology in CMN Siglo XXI, IMSS. The questionnaire SF- 36 validated in Spanish was applied. Statistical analysis: descriptive statistics with simple frequencies and percentages, inferential statistics: Fisher exact test and ANOVA to compare means.
Results: The study involved 23 patients, 14 women (60%) and 9 men (40%), mean age 38.6 ± 14.7 years. The highest score was obtained in 83% emotional role. Dimensions with further deterioration in both gen- ders were: 54% general health, vitality 59% and physical performance 72%. No differences were found regarding gender. The only issue in which statistically signi cant differences were found in patients with more than 3 comorbidities was change in health status in the past year (p=0.007). Patients with severe comorbidities, such as haematological-oncological (leukemias, lymphomas, neoplasms), and pulmonary (severe bronchiectasis) showed further deterioration in the aspects of physical performance 73% and 64% emotional role. 65% of patients reported an improvement in health status in 74% in the last year.
Conclusions: Adult patients with CVID show deterioration in different dimensions, particularly in the areas of general health, vitality and physi- cal performance. Patients with severe comorbidities such as leukemia, lymphomas, malignancies and severe bronchiectasis show further deterioration in some aspects of quality of life, especially in physical performance and emotional role. A higher number of comorbidities was signi cantly associated with a lower score in changing health. The questionnaire SF-36 is useful for evaluating the quality of life of our patients with CVID.
References
Luz L, García H, Gómez C. Confiabilidad del cuestionario de calidad de vida en salud SF-36 en Medellín, Colombia. Revista de la Facultad Nacional de Salud Pública 2006;24:37-50.
Estudios sobre la calidad de vida de pacientes afectados por determinadas patologías. Madrid: Ministerio de Sanidad y Política Social; 2009. http://www.msssi.gob.es/organizacion/sns/planCalidadSNS/docs/Estudios_calidad_vida_pacientes.pdf
Pane S, Solans M, Gaite L, et al. Instrumentos de calidad de vida relacionada con la salud en la edad pediátrica. Revisión sistemática de la literatura: actualización. Agència d’Avaluació de Tecnología i Recerca Mèdiques. Barcelona, 2006. http://www.pediatrasandalucia.org/Docs/Calidad-VidaPediatrico.pdf
Zúñiga M, Carrillo G, Fos P, et al. Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México. Salud Pública de México 1999;41:110-118.
Ware J, Sherbourne C. The MOS 36-item short-form health survey (SF-36) (I). Conceptual framework and item selection. Med Care 1992;30:473-483.
Gardulf A, Nicolay U. Replacement IgG therapy and selftherapy at home improve the health-related quality of life in patients with primary antibody deficiencies. Curr Opin Allergy Clin Immunol 2006;6:434-442.
Garratt A, Schmidt L, Mackintosh A, et al. Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 2002;324:14-17.
Vilaguta G, Ferrera M, Rajmilb L, et al. El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 2005;19:135-150.
Vargas A, Bustamante J, Muriel R, et al. Calidad de vida en Inmunodeficiencias primarias. Alergia Asma e Inmunología Pediátrica 2011;20:57-64.
Córdova H, Guarner L. Diarrea asociada a inmunodeficiencia común variable tratada con budesonida. Rev Esp Enferm Dig 2009;101:215-219.
Arostegui I, Núñez V. Aspectos estadísticos del Cuestionario de Calidad de Vida relacionada con salud Short Form-36 (SF-36). Estadística Española 2008;50:147-192.
Serra H, Barcelona P, Collino C, et al. Inmunodeficienci común variable: hallazgos recientes sobre anormalidades celulares. Acta Bioquím Clín Latinoam 2009;38:489-494.
Fernández D, Juri M, Paolini M, et al. Inmunodeficiencia común variable. Epidemiología y manifestaciones clínicas en 69 pacientes. Medicina (Buenos Aires) 2013;73:315-323.
Conley M, Notarangelo L, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Clinical Immunol 1999;93:190-197.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2014 Revista Alergia México